A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc)

التفاصيل البيبلوغرافية
العنوان: A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc)
المؤلفون: Poole, Christopher J., Lisyanskaya, A., Rodenhuis, S., Kristensen, G., Lauraine, E. Pujade, Cantarini, M., Emeribe, U., Stuart, M., Coquard, I. Ray
بيانات النشر: Oxford University Press
سنة النشر: 2010
المجموعة: The University of Warwick: WRAP - Warwick Research Archive Portal
مصطلحات موضوعية: RC0254 Neoplasms. Tumors. Oncology (including Cancer)
نوع الوثيقة: conference object
اللغة: unknown
Relation: Poole, Christopher J., Lisyanskaya, A., Rodenhuis, S., Kristensen, G., Lauraine, E. Pujade, Cantarini, M., Emeribe, U., Stuart, M. and Coquard, I. Ray (2010) A randomized phase II clinical trial of the SRC inhibitor saracatinib (AZD0530) and carboplatin plus paclitaxel (C plus P) versus C plus P in patients (pts) wiht advanced platinum-sensitive epithelial ovarian cancer (eoc). In: 35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 8-12 Oct 2010. Published in: Annals of Oncology, Volume 21 (Supplement 8). pp. 304-305. ISSN 0923-7534.
الاتاحة: https://wrap.warwick.ac.uk/id/eprint/4568/
رقم الانضمام: edsbas.7F4E4C52
قاعدة البيانات: BASE